Table 4 Liver stiffness measurement changing according to duration of antiviral therapy
| Â | Baseline vs week24 | Baseline vs week48 | ||||||
|---|---|---|---|---|---|---|---|---|
|  | Overall n = 84 | LSM \(\ge\) 8.2 n = 61 | LSM < 8.2 n = 23 | p value | Overall n = 84 | LSM \(\ge\) 8.2 n = 61 | LSM < 8.2 n = 23 | p value |
LSM decrease (%) | 14.5 (3.1–22.8) | 15.2 (6.0–22.8) | 12.6 (3.1–20.9) |  < 0.001 | 22.1 (2.1–37.8) | 23.2 (5.2–37.8) | 19.2 (2.1–33.4) |  < 0.001 |
Overall LSM decrease | ||||||||
> 10%, n (%) | 47 (55.9) | 37 (60.6) | 10 (43.5) | 0.008 | 50 (59.5) | 37 (60.6) | 13 (56.5) | 0.811 |
> 20%, n (%) | 9 (10.7) | 7 (11.5) | 2 (8.6) | 0.024 | 22 (26.2) | 18 (29.5) | 4 (17.4) |  < 0.001 |